Position in DYN
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$453,861
+$7,863 QoQ
Shares Held
20,435
-16.9% QoQ
Ownership
0.011%
of shares outstanding
% of Portfolio
0.39%
of 13F equity value
Holder Rank
#146
of 245 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in DYN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Elevate Capital Advisors, LLC holds $1,338,434 across 2 Biotechnology names. DYN ranks #2 (33.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ROIV |
Roivant Sciences Ltd.
|
24,995 | $884,573 | |
| 2 | DYN |
Dyne Therapeutics, Inc.
This page
|
20,435 | $453,861 |
All Filings in DYN
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $453,861 | 20,435 | Shares | Sole | 2026-07-31 | |
| 2026-03-31 | $445,998 | 24,600 | Shares | Sole | 2026-04-24 | |
| 2025-12-31 | $471,669 | 24,114 | Shares | Sole | 2026-01-23 | |
| No filing history on record for this holder in this stock. | ||||||